This inventor holds 5 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignee: Merz Pharma Gmbh & Co Kgaa. Active years: 2015-2024.
Company Filing History:
Years Active: 2015-2024
Title: Gerd J Mander: Innovator in Biological Activity Determination
Introduction
Gerd J Mander is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for determining biological activity in cells.
Latest Patents
Mander holds 5 patents, with his latest invention focusing on the determination of the biological activity of BoNT/E in cells. This invention involves a polyclonal or monoclonal antibody that specifically binds to BoNT/E-cleaved SNAP-25. The method includes several steps, such as incubating susceptible cells with BoNT/E, fixing the cells, and using capture and detection antibodies to measure the biological activity of BoNT/E.
Career Highlights
Gerd J Mander is associated with Merz Pharma GmbH & Co. KGaA, where he applies his expertise in biotechnology. His work has been instrumental in advancing methods that enhance our understanding of biological processes.
Collaborations
Mander has collaborated with notable colleagues, including Markus Burger and Harold Victor Taylor, contributing to the innovative research environment at Merz Pharma.
Conclusion
Gerd J Mander's work exemplifies the intersection of innovation and biotechnology, showcasing his commitment to advancing scientific knowledge and practical applications in the field.